[Study of hemostasis factors in nephrotic syndrome. Pathogenic interpretation and therapeutic deductions].
Thrombo-embolic accidents are extremely common during nephrotic syndrome (8 p. 100). They share the garvity of thrombo-embolic accidents occurring under other circumstances (20 p. 100 mortality). They are accompanied by numerous disturbances in clotting factors the mechanisms of which are discussed. Nevertheless the study of these disturbances does not make it possible to predict the onset of a thrombo-embolic problem. By contrast, the degree of hypoalbuminaemia is significantly correlated with the thrombotic risk (p. 0.001) and serves as an indication for the necessity of preventive heparin therapy, in the form of calcium heparinate. In this way the authors have been successful in eliminating the thrombo-embolic risk in association with nephrotic syndrome.
D001772:Blood Cell Count; D001779:Blood Coagulation Factors / Q000032:analysis; D001780:Blood Coagulation Tests; D001792:Blood Platelets; D005165:Factor V / Q000032:analysis; D005169:Factor VIII / Q000032:analysis; D005170:Factor X / Q000032:analysis; D005340:Fibrinogen / Q000032:analysis; D005921:Glomerulonephritis / Q000097:blood* / Q000150:complications; D006487:Hemostasis; D006801:Humans; D009404:Nephrotic Syndrome / Q000097:blood* / Q000150:complications; D011516:Prothrombin / Q000032:analysis; D013923:Thromboembolism / Q000517:prevention & control
D001779:Blood Coagulation Factors; D005165:Factor V; D011516:Prothrombin; D005169:Factor VIII; D005170:Factor X; D005340:Fibrinogen
Etude des facteurs de l'hémostase au cours des syndromes néphrotiques. Interprétation pathogénique de déductions thérapeutiques.